(MedPage Today) -- Patients taking GLP-1 receptor agonists (GLP-1RAs) had a lower likelihood of developing age-related macular degeneration (AMD) compared with patients using other glucose-lowering medications or lipid-lowering drugs, a large retrospective...

Send this story to anyone — or drop the embed into a blog post, Substack, Notion page. Every play sends rev-share back to MedPage Today.

𝕏 Post on X in Share on LinkedIn ✉ Email a friend

Heard via Storyflo

Get audio versions of every article you read.

Pick what matters — your audio curator gets you into your daily flo.

Join the listener waitlist

More Evidence that GLP-1s May Reduce Risk of Vision-Robbing Eye Diseases · Storyflo